Back to Authors

Owen, C

Mayo Clinic

Eli Lilly (United States)

Citations 1

Effects of mirikizumab versus placebo on histologic inflammation evaluated by comprehensive assessment in 5 intestinal segments in a randomized controlled phase 3 trial of participants with Crohn’s disease
Feagan, Brian, D’Haens, Geert , Pai, Rish K. , Protić, Marijana , Escobar, Rodrigo , Reinisch, Walter, Jairath, Vipul , Magro, Fernando , Hertogh, Gert D. , Harpaz, Noam , Hisamatsu, T, Hon, Kam‐Lun Ellis , Owen, C, Reinisch, Walter , Siegmund, Britta

Zeitschrift für Gastroenterologie | September 4, 2025 | Volume: 63 | Issue: No issue available | Pages: No page available

10.1055/s-0045-1810728 Get It